JordanJerrellAtkinsMDMPHS

PubMed

• 1 citations
  Racial Disparities in the Outcomes of Patients With Stage IV Pancreatic Adenocarcinoma Are Mediated by Chemotherapy Utilization.
  Jordan Atkins, Mark A. Fiala, Andrea Wang-Gillam, Tanya M. Wildes
  Pancreas. 2016-08-01
• 15 citations
  Which Imaging Modality Is Superior for Prediction of Response to Neoadjuvant Chemotherapy in Patients with Triple Negative Breast Cancer
  Jordan Atkins, Catherine M. Appleton, Carla S. Fisher, Feng Gao, Julie A. Margenthaler
  Journal of Oncology. 2013-02-11
• 59 citations
  Positive margin rates following breast-conserving surgery for stage I–III breast cancer: palpable versus nonpalpable tumors
  Jordan Atkins, Fatema Al Mushawah, Catherine M. Appleton, Amy E. Cyr, William E. Gillanders
  The Journal of Surgical Research. 2012-09-01

Abstracts/Posters

• Efficacy of Desensitization Therapy for Donor-specific Anti-HLA Antibodies in Patients Undergoing Haploidentical Hematopoietic Cell Transplant.
  Atkins J, Slade M, DiPersio JF, Westervelt P, Vij R, Gao F, Zou J, Romee R., 25th Anniversary American Society of Blood and Marrow Transplantation, Poster session., Salt Lake City,UT
• Efficacy of Desensitization Therapy for Donor-specific Anti-HLA Antibodies in Patients Undergoing Haploidentical Hematopoietic Cell Transplant.
  Atkins J, Slade M, DiPersio JF, Westervelt P, Vij R, Gao F, Zou J, Romee R., 25th Anniversary American Society of Blood and Marrow Transplantation, Poster session, Salt Lake City, UT, 2/21/2018
• Racial Disparities in the Outcomes of Patients with Stage IV Pancreatic Adenocarcinoma are Mediated by Chemotherapy Utilization.
  Atkins J, Fiala M, Wang-Gillam A, Wildes TM, Pancreas; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, 1/1/2016
• Efficacy of Bortezomib-Based Regimens with or Without an Immunomodulatory Agent in Older Adults with Multiple Myeloma: A Systematic Review and Meta-Analysis.
  Atkins J, Fowler SA, Tuuli M, James SA, Wildes TM, Blood; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, 1/15/2013
• Which Imaging Modality Is Superior for Prediction of Response to Neoadjuvant Chemotherapy in Patients with Triple Negative Breast Cancer?
  Atkins J, Appleton CM, Fisher CS, Gao F, Margenthaler JA, Journal of Oncology; Department of Surgery, Washington University School of Medicine, St. Louis, MO, 1/14/2013
• Fear of Recurrence and Perceived Survival Benefit are Primary Motivators for Choosing Mastectomy over Breast-Conservation Therapy Regardless of Age.
  Fisher CS, Martin-Dunlap T, Ruppel MB, Gao F, Atkins J, Margenthaler JA, Ann Surg Oncol; Department of Surgery, Perelman School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 1/26/2012
• Which Imaging Modality Is Superior for Prediction of Response to Neoadjuvant Chemotherapy in Patients with Triple Negative Breast Cancer?
  Atkins J, Cyr A, Appleton CM, Fisher CS, Margenthaler, JA, 7th Annual Academic Surgical Congress, Clinical Trials and Outcomes 3 - Prognostic Factors & Surgical Predictors; ASC20120484, Las Vegas, NV, 1/14/2012
• Positive Margin Rates Following Breast-Conserving Surgery for Stage I-III Breast Cancer: Palpable Versus Non-Palpable Tumors?
  Atkins J, Mushawah FA, Cyr A, Aft RL, Gillanders WE, Eberlein TJ, Margenthaler JA, 7th Annual Academic Surgical Congress; Clinical Trials and Outcomes 3 - Prognostic Factors & Surgical Predictors; ASC20120211, Las Vegas, NV, 1/14/2012
• Reconstruction Patterns in a Single Institution Cohort of Women Undergoing Mastectomy for Breast Cancer.
  Elmore L, Myckatyn TM, Gao F, Fisher CS, Atkins J, Martin-Dunlap TM, Margenthaler JA, Ann Surg Oncol; Department of Surgery, Washington University School of Medicine, St. Louis, MO, 1/10/2012
• Which Imaging Modality Is Superior for Prediction of Response to Neoadjuvant Chemotherapy in Patients with Triple Negative Breast Cancer?
  Atkins J, Cyr A, Appleton CM, Fisher CS, Margenthaler JA, 45th Annual Professional Meeting, Committee of Cancer Abstract Contest, Missouri Chapter of the American College of Surgeons, Lake Ozark, MO, 1/8/2012
• Which Imaging Modality Is Superior for Prediction of Response to Neoadjuvant Chemotherapy in Patients with Triple Negative Breast Cancer?
  Atkins J, Cyr A, Appleton CM, Fisher CS, Margenthaler JA, Committee of Cancer Abstract Contest, Missouri Chapter of the American College of Surgeons, 45th Annual Professional Meeting, Lake Ozark, MO, 1/8/2012
• Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors.
  Atkins J, Mushawah FA, Appleton CM, Cyr AE, Gillanders WE, Aft RL, Eberlein TJ, Gao F, Margenthaler JA, J Surg Res; Department of Surgery, Washington University School of Medicine, St. Louis, MO, 1/1/2012
• Knockdown of DDX21 using RNA interference via lentiviral delivery in breast cancer cell lines implicates its potential nuclear activity through its negative impact on ...
  Atkins J, Zhang Y, Weber J, 5th Annual Research Training Symposium and Poster Session, St. Louis, MO, 1/27/2010
• Join now to see all